Artelo Biosciences (ARTL) EPS (Diluted) (2017 - 2025)
Artelo Biosciences (ARTL) EPS (Diluted) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | -8.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.05 |
| Sep 30, 2025 | -12.18 |
| Jun 30, 2025 | -19.21 |
| Mar 31, 2025 | -13.06 |
| Dec 31, 2024 | -53.00 |
| Sep 30, 2024 | -6.71 |
| Jun 30, 2024 | -14.12 |
| Mar 31, 2024 | -14.67 |
| Dec 31, 2023 | -19.70 |
| Sep 30, 2023 | -16.15 |
| Jun 30, 2023 | -142.47 |
| Mar 31, 2023 | -181.48 |
| Dec 31, 2022 | -273.52 |
| Sep 30, 2022 | -189.05 |
| Jun 30, 2022 | -196.45 |
| Mar 31, 2022 | -151.54 |
| Nov 30, 2021 | -201.02 |
| Aug 31, 2021 | -298.02 |
| May 31, 2021 | -183.39 |
| Feb 28, 2021 | -158.84 |